News & Events
2023
RADBIO announces a strategic alliance with MBC BioLabs in order to relocate our corporate headquarters to the San Francisco Bay Area of California.
MBC BioLabs brings together small life science companies with the largest biotech companies, creating mutually beneficial relationships, alliances, and opportunities for both entrepreneurs and corporate partners, such as Johnson & Johnson, AbbVie, Astellas, Bristol Myers Squibb, Eisai, and Eli Lilly, among others.
RADBIO presented its findings at the 3rd Annual TGF-beta for Immuno-Oncology Summit held in San Francisco, California.
RADBIO will be present at Biotech Showcase™. January 9-11, 2023.
The company will present its development programs in Systemic Sclerosis and safety studies at the Seed Showcase, Wednesday, January 11th, 11:10AM at Franciscan D (Ballroom Level)
2022
We are proud to have been awarded first prize at the #ConcursoSolucionesInnovadorasBancoNación2022 in the category “people-oriented solutions”.
The contest, organized by Fundación Empretec Argentina and Banco de la Nación Argentina, had more than 1,000 applications, among which RADBIO achieved first place in its category.
RADBIO will be present at ChinaBio® Partnering Forum. Nov 8-11, 2022.
The company will present its advances in Skin and Pulmonary fibrosis.
RADBIO will be present at Biotech Showcase™ Virtually. January 10-19, 2022.
We will be presenting recent safety studies performed with our pan-TGFβ neutralizing peptibody, BRECEPT.
2021
Dr. Ricardo Dewey has been awarded the first César Milstein Prize to the research in biotechnology with an impact on human health.
The award was presented by the president of CONICET, Ana Franchi; the Minister of Science, Technology and Innovation of the Nation, Daniel Filmus; the president of the Cassará Foundation, Jorge Cassará; and the director of ICT Milstein, Adrián Vojnov.
RADBIO will be present at BioSpain Trade Show & Partnering. Sep 27-Oct 1, 2021.
RADBIO will attend the BioSpain Trade Show & Partnering on Sep 27-Oct 1, 2021. The company will present its “inhibitor of the TGF-β signaling pathway for the treatment of fibrotic diseases and cancer” programs.
RADBIO will be present at ChinaBio® Partnering Forum. May 10-14, 2021.
RADBIO will attend the ChinaBio® Partnering Forum on May 10-14,2021. The company will present its “inhibitor of the TGF-β signaling pathway for the treatment of fibrotic diseases and cancer” programs.
RADBIO will be present at Bio-Europe Spring® Digital. March 22-25, 2021.
RADBIO will attend the BIO-EUROPE SPRING® Digital on March 22-25, 2021. The company will present its “latest updates in cutaneous and pulmonary fibrosis for the treatment of Systemic Sclerosis” programs.
RADBIO will be present at Biotech Showcase™ Digital. January 11-15, 2021.
RADBIO will attend the Biotech Showcase™ Digital on January 11-15, 2021. The company will present its development programs in Systemic Sclerosis, Liver Fibrosis, and Cancer.